
|Videos|October 11, 2016
Atopic Dermatitis: Determining Utilization Management Criteria for Long-Term Systemic Therapies
Advertisement
Episodes in this series

Panelists Peter L. Salgo, MD; Jonathan Silverberg, MD, PhD, MPH; Jeffrey D. Dunn, PharmD, MBA; Cheryl Allen, BS Pharm, MBA; and Ed Pezalla, MD, MPH, discuss determining and recognizing utilization management for long-term systemic therapies in patients with atopic dermatitis.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists Can Close the LDL Control Gap in Lipid Care
2
Pharmacists as the Glue in Cardio-Kidney-Metabolic Care
3
FDA Approves Apitegromab-mstn, First Muscle-Targeted SMA Therapy
4
Building a CDTM Program Means Starting Small
5
























































































































